Latest FDA Stories
Celgene Launches Psoriatic Arthritis Educational Patient-Focused Program SUMMIT, N.J., Feb.
Lawsuit website reports recent announcement by Bayer and Johnson & Johnson that they will push for further FDA approvals for Xarelto, while lawsuits against them are consolidated in multidistrict litigation
ARM requests additional clarity on a number of points within the guidance and recommends the FDA hold a public hearing to facilitate discussion with stakeholders. WASHINGTON,
On March 10, join one of the world’s top device packaging experts — Abhi Gautam of ConMed — for a case study-driven webinar that will teach attendees how to leverage a risk-based packaging
New System Slated for Introduction at American Academy of Dermatology 2015 Annual Meeting WESTFORD, Mass., Feb.
Former FDA official stresses agency's existing authority to regulate public health WASHINGTON, Feb.
BALA CYNWYD, Pa., Feb. 24, 2015 /PRNewswire/ -- Thousands of patients in the U.S.
- Farydak, an HDAC inhibitor with epigenetic activity, approved in combination for patients who received at least two prior regimens including bortezomib and IMiD1 EAST HANOVER, N.J., Feb.
PPMD's Annual Advocacy Conference Focused on Implementing MD-CARE Act Amendments & Strengthening Patient Voice at FDA WASHINGTON, Feb.
Nestlé announced that it will remove artificial colors and flavors from its chocolate candies by the end of 2015, noting this is an important issue to consumers. But why are artificial colors and flavors believed to be so bad, and how wary of them should we really be?
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.